Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults
- Resource Type
- Article
- Source
- In
Vaccine 17 April 2014 32(19):2251-2259 - Subject
- Language
- ISSN
- 0264-410X